Pelthos Therapeutics PTHS
NYSE PTHS
$20.77 +0.11 (+0.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Depreciation and Depletion (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) recorded Depreciation and Depletion of $278,000 in Q2 2026, down 40.7% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Depreciation and Depletion (2025 - 2026) Analysis & Trends

On a TTM basis, Pelthos Therapeutics' Depreciation and Depletion came in at $1.48 million as of Jun 30, 2026; for FY2025, it was $729,000.

  • Quarterly Depreciation and Depletion has ranged from $74,000 in Q3 2025 to $655,000 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $469,000 (Q1 2026), $655,000 (Q4 2025) and $74,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Pelthos Therapeutics 77.24 Mn -11.16 Mn 11.99 Mn 278,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 278,000.00
Mar 31, 2026 469,000.00
Dec 31, 2025 655,000.00
Sep 30, 2025 74,000.00
API Access

Pelthos Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PTHS&period=max&api_key=YOUR_API_KEY